Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus

BACKGROUND: Emerging data demonstrate that the use of integrase inhibitor (INSTI)-based antiretroviral treatment (ART) is associated with increased weight, but the cardiometabolic health consequences of increased weight remains poorly understood. METHODS: This analysis examined INSTI use (>6 mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Kileel, Emma M, Lo, Janet, Malvestutto, Carlos, Fitch, Kathleen V, Zanni, Markella V, Fichtenbaum, Carl J, Overton, Edgar T, Okeke, Nwora Lance, Kumar, Princy, Joao, Esau, Aberg, Judith A, Martinez, Esteban, Currier, Judith S, Douglas, Pamela S, Ribaudo, Heather J, Grinspoon, Steven K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651160/
https://www.ncbi.nlm.nih.gov/pubmed/34888395
http://dx.doi.org/10.1093/ofid/ofab537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651160/
https://www.ncbi.nlm.nih.gov/pubmed/34888395
http://dx.doi.org/10.1093/ofid/ofab537

Ejemplares similares